Both in Pharmaceuticals
Karyopharm Therapeutics vs Kyntra Bio
Over the past year KPTI returned −85.3% and KYNB returned −28.5%; their daily moves had a correlation of 0.09.
KPTI −85.3% KYNB −28.5%Growth of $1, one year, split-adjusted
| Metric | KPTI | KYNB |
|---|---|---|
| Price | $1.21 | $6.79 |
| Market cap | $27.3M | $27.5M |
| Today | −25.62% | −1.59% |
| 1 month | −35.6% | −15.3% |
| 6 months | −77.3% | +5.1% |
| Year to date | −83.6% | — |
| 1 year | −81.6% | — |
| Revenue growth (YoY) | −11.9% | — |
| Gross margin | 96.8% | — |
| Net margin | −200.5% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.2× | — |
| Net cash | -$184.8M | $91.3M |
| Dividend yield | — | — |
| Volatility (60d) | 281.5% | 40.3% |
| Short % of float | 37.9% | 2.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).